TNF-α induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin

[1]  R. Schulz,et al.  Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion , 2008, Basic Research in Cardiology.

[2]  P. Couraud,et al.  Differential effects of hydrocortisone and TNFα on tight junction proteins in an in vitro model of the human blood–brain barrier , 2008, The Journal of physiology.

[3]  Brian H Cuthbertson,et al.  Hydrocortisone therapy for patients with septic shock. , 2008, The New England journal of medicine.

[4]  Vijay G Divakaran,et al.  Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor. , 2008, Basic research in cardiology.

[5]  U. Welsch,et al.  Heparinase selectively sheds heparan sulphate from the endothelial glycocalyx , 2008, Biological chemistry.

[6]  U. Welsch,et al.  Hydrocortisone Preserves the Vascular Barrier by Protecting the Endothelial Glycocalyx , 2007, Anesthesiology.

[7]  K. Peter,et al.  Shedding of the Endothelial Glycocalyx in Patients Undergoing Major Vascular Surgery With Global and Regional Ischemia , 2007, Circulation.

[8]  C. Tschöpe,et al.  Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy , 2007, Basic Research in Cardiology.

[9]  U. Welsch,et al.  The Endothelial Glycocalyx Prefers Albumin for Evoking Shear Stress-Induced, Nitric Oxide-Mediated Coronary Dilatation , 2007, Journal of Vascular Research.

[10]  R. Erbel,et al.  Release of TNF-alpha during stent implantation into saphenous vein aortocoronary bypass grafts and its relation to plaque extrusion and restenosis. , 2007, American journal of physiology. Heart and circulatory physiology.

[11]  U. Welsch,et al.  The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels. , 2007, Cardiovascular research.

[12]  R. Erbel,et al.  Bidirectional Role of Tumor Necrosis Factor-&agr; in Coronary Microembolization: Progressive Contractile Dysfunction Versus Delayed Protection Against Infarction , 2007, Circulation research.

[13]  N. Tewari-Singh,et al.  Tumor Necrosis Factor-α Induces Endothelial Dysfunction in Leprdb Mice , 2007 .

[14]  Vijay G Divakaran,et al.  Transforming growth factor-β receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor , 2007, Basic Research in Cardiology.

[15]  KA Brown,et al.  Neutrophils in development of multiple organ failure in sepsis , 2006, The Lancet.

[16]  M. Focardi,et al.  Tumor Necrosis Factor- (cid:1) Induces Endothelial Dysfunction in the Prediabetic Metabolic Syndrome , 2022 .

[17]  A. Boyer,et al.  Glucocorticoid treatment in patients with septic shock: effects on vasopressor use and mortality. , 2006, International journal of clinical pharmacology and therapeutics.

[18]  J. Kastelein,et al.  Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. , 2006, Diabetes.

[19]  A. Pries,et al.  Normal endothelium. , 2006, Handbook of experimental pharmacology.

[20]  R. Sanderson,et al.  Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: Growth regulation and the prospect of new cancer therapies , 2005, Journal of cellular biochemistry.

[21]  D. Annane.  Glucocorticoids in the treatment of severe sepsis and septic shock , 2005, Current opinion in critical care.

[22]  S. Zahler,et al.  Intracoronary formation and retention of micro aggregates of leukocytes and platelets contribute to postischemic myocardial dysfunction , 2005, Basic Research in Cardiology.

[23]  S. Zahler,et al.  Endothelial Glycocalyx as an Additional Barrier Determining Extravasation of 6% Hydroxyethyl Starch or 5% Albumin Solutions in the Coronary Vascular Bed , 2004, Anesthesiology.

[24]  A. Mulivor,et al.  Inflammation- and ischemia-induced shedding of venular glycocalyx. , 2004, American journal of physiology. Heart and circulatory physiology.

[25]  Y. Anfinogenova,et al.  Histaminergic Regulation of Smooth Muscles in Rabbit Pulmonary Arteries , 2001, Bulletin of Experimental Biology and Medicine.

[26]  E. Czarnowska,et al.  Ultrastructural demonstration of endothelial glycocalyx disruption in the reperfused rat heart. Involvement of oxygen free radicals , 1995, Basic Research in Cardiology.

[27]  Shumei Yang,et al.  Glucocorticoids and vascular reactivity. , 2004, Current vascular pharmacology.

[28]  S. Zahler,et al.  Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. , 2003, Cardiovascular research.

[29]  J. Spaan,et al.  Endothelial Cell Glycocalyx Modulates Immobilization of Leukocytes at the Endothelial Surface , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[30]  Hans Vink,et al.  The Endothelial Glycocalyx Protects Against Myocardial Edema , 2003, Circulation research.

[31]  J. Briegel,et al.  Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery , 2003, Critical care medicine.

[32]  J. Hoffmann,et al.  Antithrombin: a new look at the actions of a serine protease inhibitor , 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[33]  A. Mulivor,et al.  Role of glycocalyx in leukocyte-endothelial cell adhesion. , 2002, American journal of physiology. Heart and circulatory physiology.

[34]  S. Zahler,et al.  Selectin-mediated rolling of neutrophils is essential for their activation and retention in the reperfused coronary system , 2002, Basic Research in Cardiology.

[35]  M. Moskowitz,et al.  Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase , 2002, Nature Medicine.

[36]  G. Heusch,et al.  Myocardial Dysfunction With Coronary Microembolization: Signal Transduction Through a Sequence of Nitric Oxide, Tumor Necrosis Factor-&agr;, and Sphingosine , 2002, Circulation research.

[37]  B. Duling,et al.  TNF‐α Modulates Arteriolar Reactivity Secondary to a Change in Intimal Permeability , 2000 .

[38]  B. Duling,et al.  TNF-α increases entry of macromolecules into luminal endothelial cell glycocalyx , 2000 .

[39]  F. Baudo,et al.  [Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] . , 2000, Minerva anestesiologica.

[40]  A. Pries,et al.  Influence of the Endothelial Glycocalyx on Cerebral Blood Flow in Mice , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[41]  T. W. Secomb,et al.  The endothelial surface layer , 2000, Pflügers Archiv.

[42]  J. Spaan,et al.  Oxidized lipoproteins degrade the endothelial surface layer : implications for platelet-endothelial cell adhesion. , 2000, Circulation.

[43]  B. Duling,et al.  TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. , 2000, American journal of physiology. Heart and circulatory physiology.

[44]  B. Duling,et al.  TNF-alpha modulates arteriolar reactivity secondary to a change in intimal permeability. , 2000, Microcirculation.

[45]  D. Epstein,et al.  Glucocorticoids regulate transendothelial fluid flow resistance and formation of intercellular junctions. , 1999, American journal of physiology. Cell physiology.

[46]  T. Mempel,et al.  Reduction of oxygen delivery during post-ischemic reperfusion protects the isolated guinea pig heart , 1999, Basic Research in Cardiology.

[47]  S. Kushimoto,et al.  Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin. , 1999, Blood.

[48]  O. Kemmotsu,et al.  Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. , 1998, Critical care medicine.

[49]  M. Uchiba,et al.  The Anti-Inflammatory Properties of Antithrombin III: New Therapeutic Implications , 1998, Seminars in thrombosis and hemostasis.

[50]  B. F. Becker.  Towards the physiological function of uric acid. , 1993, Free radical biology & medicine.

[51]  J. Beach,et al.  Modification of vascular reactivity by alteration of intimal permeability: effect of TNF-alpha. , 1993, The American journal of physiology.

[52]  P. Marsden,et al.  Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism , 1990, The Journal of experimental medicine.

[53]  J. Grünfeld,et al.  Glucocorticoids modulate vascular reactivity in the rat. , 1987, Hypertension.

[54]  I. Cohen,et al.  Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. , 1987, Blood.

[55]  R. Dudziak,et al.  [Determination of the plasma elimination of hydroxyethyl starch and dextran using improved analytical methods]. , 1981, Infusionstherapie und klinische Ernahrung.

[56]  H. Neurath,et al.  Mast cell proteases. , 1981, Methods in enzymology.